PubMed for id: 549433030

Year	Number of Results
2013	2
2014	2
2015	1
2016	1
2021	5
2024	0

1

Expression and clinical significance of lncRNA-SChLAP1 in breast cancer.

Cheng S, Zhao Q, Zheng Z. Cheng S, et al. J BUON. 2021 May-Jun;26(3):728-733. J BUON. 2021. PMID: 34268927 Free article.

2

High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneity.

Kidd SG, Carm KT, Bogaard M, Olsen LG, Bakken AC, Løvf M, Lothe RA, Axcrona K, Axcrona U, Skotheim RI. Kidd SG, et al. Neoplasia. 2021 Jun;23(6):634-641. doi: 10.1016/j.neo.2021.05.012. Epub 2021 Jun 7. Neoplasia. 2021. PMID: 34107378 Free PMC article.

3

SChLAP1 contributes to non-small cell lung cancer cell progression and immune evasion through regulating the AUF1/PD-L1 axis.

Du Z, Niu S, Wang J, Wu J, Li S, Yi X. Du Z, et al. Autoimmunity. 2021 Jun;54(4):225-233. doi: 10.1080/08916934.2021.1913582. Epub 2021 Apr 27. Autoimmunity. 2021. PMID: 33904361

4

Long non‑coding RNA SChLAP1 regulates the proliferation of triple negative breast cancer cells via the miR‑524‑5p/HMGA2 axis.

Bai X, Zhang S, Qiao J, Xing X, Li W, Zhang H, Xie J. Bai X, et al. Mol Med Rep. 2021 Jun;23(6):446. doi: 10.3892/mmr.2021.12085. Epub 2021 Apr 13. Mol Med Rep. 2021. PMID: 33846810 Free PMC article.

5

SChLAP1 promotes prostate cancer development through interacting with EZH2 to mediate promoter methylation modification of multiple miRNAs of chromosome 5 with a DNMT3a-feedback loop.

Huang K, Tang Y. Huang K, et al. Cell Death Dis. 2021 Feb 15;12(2):188. doi: 10.1038/s41419-021-03455-8. Cell Death Dis. 2021. PMID: 33589600 Free PMC article.

6

Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer.

Mehra R, Udager AM, Ahearn TU, Cao X, Feng FY, Loda M, Petimar JS, Kantoff P, Mucci LA, Chinnaiyan AM. Mehra R, et al. Eur Urol. 2016 Oct;70(4):549-552. doi: 10.1016/j.eururo.2015.12.003. Epub 2015 Dec 24. Eur Urol. 2016. PMID: 26724257 Free PMC article.

7

A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer.

Mehra R, Shi Y, Udager AM, Prensner JR, Sahu A, Iyer MK, Siddiqui J, Cao X, Wei J, Jiang H, Feng FY, Chinnaiyan AM. Mehra R, et al. Neoplasia. 2014 Dec;16(12):1121-7. doi: 10.1016/j.neo.2014.11.006. Neoplasia. 2014. PMID: 25499224 Free PMC article.

8

RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1.

Prensner JR, Zhao S, Erho N, Schipper M, Iyer MK, Dhanasekaran SM, Magi-Galluzzi C, Mehra R, Sahu A, Siddiqui J, Davicioni E, Den RB, Dicker AP, Karnes RJ, Wei JT, Klein EA, Jenkins RB, Chinnaiyan AM, Feng FY. Prensner JR, et al. Lancet Oncol. 2014 Dec;15(13):1469-1480. doi: 10.1016/S1470-2045(14)71113-1. Epub 2014 Nov 17. Lancet Oncol. 2014. PMID: 25456366 Free PMC article.

9

Linking the SWI/SNF complex to prostate cancer.

Lee RS, Roberts CW. Lee RS, et al. Nat Genet. 2013 Nov;45(11):1268-9. doi: 10.1038/ng.2805. Nat Genet. 2013. PMID: 24165726

10

The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex.

Prensner JR, Iyer MK, Sahu A, Asangani IA, Cao Q, Patel L, Vergara IA, Davicioni E, Erho N, Ghadessi M, Jenkins RB, Triche TJ, Malik R, Bedenis R, McGregor N, Ma T, Chen W, Han S, Jing X, Cao X, Wang X, Chandler B, Yan W, Siddiqui J, Kunju LP, Dhanasekaran SM, Pienta KJ, Feng FY, Chinnaiyan AM. Prensner JR, et al. Nat Genet. 2013 Nov;45(11):1392-8. doi: 10.1038/ng.2771. Epub 2013 Sep 29. Nat Genet. 2013. PMID: 24076601 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year